Palbociclib and Pembrolizumab in Sarcoma

NCT06113809 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma

Interventions

DRUG: Palbociclib
DRUG: Pembrolizumab

Sponsor

John Rieth